Emerging research directions include investigation of senescence heterogeneity and tissue-specific senescent cell populations, with FOXO4-DRI serving as a tool for studying how different senescent cell types contribute to various pathological processes
Another Phase Ib/II trial exploring the safety and efficacy of capmatinib treatment with cetuximab, an anti-EGFR antibody, in HNSCC and metastatic colorectal cancers positive for c-MET has recently been suspended for unknown reasons (NCT02205398)
The degradation is silent
Zhu C, Lai Y, Liu C, Teng L, Zhu Y, Lin X, et al
Two things can shift your thyroid needs during weight loss: Absorption variability (especially early on with dose increases) BNF Body weight changes (thyroid replacement dose requirements can change as weight changes) A practical approach many clinicians use is: Check TSH ( free T4) about 68 weeks after : starting tirzepatide, or a significant dose escalation, or a big, sustained drop in weight NICE also flags that because tirzepatide delays gastric emptying, some oral medicines (particularly those with a narrow therapeutic index) may need monitoring during escalation
Phase Reta escalation 1 Weeks 5-8 Retatrutide 4 mg/week Cagrilintide Not started Notes Continue retatrutide alone